← Open Payments lookup

ANGELA GRANT: Open Payments

NPI 1649822479 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$970 in 51 payments from 15 companies in 2025. Trend: 2023 $749 · 2024 $1,017 · 2025 $970

Food & beverage: $958Education: $12
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$160
Vanda Pharmaceuticals Inc.8$153
Otsuka America Pharmaceutical, Inc.10$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$108
Janssen Scientific Affairs, LLC2$65
Axsome Therapeutics, Inc.4$61
E.R. Squibb & Sons, L.L.C.3$59
Lundbeck LLC2$50
Janssen Pharmaceuticals, Inc2$40
Neurocrine BioSciences, Inc.1$24

Products named: FANAPT, AUSTEDO XR, REXULTI, CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, Auvelity, COBENFY.

Industry payments across ID — which companies pay providers there.